Kathleen Maksimowicz-McKinnon
Patterns of arterial disease in Takayasu's Arteritis and Giant Cell Arteritis
Maksimowicz-McKinnon, Kathleen; Gribbons, K. Bates; Ponte, Cristina; Carette, Simon; Craven, Anthea; Cuthbertson, David; Hoffman, Gary S.; Khalidi, Nader A.; Koening, Curry L.; Langford, Carol A.; Maksimowicz?McKinnon, Kathleen; McAlear, Carol A.; Monach, Paul A.; Moreland, Larry W.; Pagnoux, Christian; Quinn, Kaitlin A.; Robson, Joanna C.; Seo, Philip; Sreih, Antoine G.; Suppiah, Ravi; Warrington, Kenneth J.; Ytterberg, Steven R.; Luqmani, Raashid; Watts, Richard; Merkel, Peter A.; Grayson, Peter C.
Authors
K. Bates Gribbons
Cristina Ponte
Simon Carette
Anthea Craven
David Cuthbertson
Gary S. Hoffman
Nader A. Khalidi
Curry L. Koening
Carol A. Langford
Kathleen Maksimowicz?McKinnon
Carol A. McAlear
Paul A. Monach
Larry W. Moreland
Christian Pagnoux
Kaitlin A. Quinn
Jo Robson Jo.Robson@uwe.ac.uk
Consultant Associate Professor in Rheumatology
Philip Seo
Antoine G. Sreih
Ravi Suppiah
Kenneth J. Warrington
Steven R. Ytterberg
Raashid Luqmani
Richard Watts
Peter A. Merkel
Peter C. Grayson
Abstract
Published 2019. This article is a U.S. Government work and is in the public domain in the USA. Objective: To identify and validate, using computer-driven methods, patterns of arterial disease in Takayasu arteritis (TAK) and giant cell arteritis (GCA). Methods: Patients with TAK or GCA were studied from the Diagnostic and Classification Criteria for Vasculitis (DCVAS) cohort and a combined North American cohort. Case inclusion required evidence of large-vessel involvement, defined as stenosis, occlusion, or aneurysm by angiography/ultrasonography, or increased 18F-fluorodeoxyglucose (FDG) uptake by positron emission tomography (PET) in at least 1 of 11 specified arterial territories. K-means cluster analysis identified groups of patients based on the pattern of arterial involvement. Cluster groups were identified in the DCVAS cohort and independently validated in the North American cohort. Results: A total of 1,068 patients were included (DCVAS cohort: TAK = 461, GCA = 217; North American cohort: TAK = 225, GCA = 165). Six distinct clusters of patients were identified in DCVAS and validated in the North American cohort. Patients with TAK were more likely to have disease in the abdominal vasculature, bilateral disease of the subclavian and carotid arteries, or focal disease limited to the left subclavian artery than GCA (P < 0.01). Patients with GCA were more likely to have diffuse disease, involvement of bilateral axillary/subclavian arteries, or minimal disease without a definable pattern than TAK (P < 0.01). Patients with TAK were more likely to have damage by angiography, and patients with GCA were more likely to have arterial FDG uptake by PET without associated vascular damage. Conclusion: Arterial patterns of disease highlight both shared and divergent vascular patterns between TAK and GCA and should be incorporated into classification criteria for large-vessel vasculitis.
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 16, 2019 |
Online Publication Date | Aug 23, 2019 |
Publication Date | Nov 1, 2020 |
Deposit Date | May 15, 2020 |
Journal | Arthritis Care and Research |
Print ISSN | 2151-464X |
Electronic ISSN | 2151-4658 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 72 |
Issue | 11 |
Pages | 1615-1624 |
DOI | https://doi.org/10.1002/acr.24055 |
Keywords | Rheumatology |
Public URL | https://uwe-repository.worktribe.com/output/5975179 |
Additional Information | Published: 2019-08-23 |
You might also like
The OMERACT emerging leaders program: The good, the bad, and the future
(2019)
Journal Article
Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018
(2019)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search